scispace - formally typeset
I

Ilseung Cho

Researcher at New York University

Publications -  33
Citations -  6495

Ilseung Cho is an academic researcher from New York University. The author has contributed to research in topics: Gut flora & Microbiome. The author has an hindex of 16, co-authored 30 publications receiving 5553 citations. Previous affiliations of Ilseung Cho include Veterans Health Administration & United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

The human microbiome: at the interface of health and disease

TL;DR: The large-scale dynamics of the microbiome can be described by many of the tools and observations used in the study of population ecology, andiphering the metagenome and its aggregate genetic information can also be used to understand the functional properties of the microbial community.
Journal ArticleDOI

Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences

TL;DR: It is shown that low-dose penicillin (LDP), delivered from birth, induces metabolic alterations and affects ileal expression of genes involved in immunity, indicating that microbiota interactions in infancy may be critical determinants of long-term host metabolic effects.
Journal ArticleDOI

Antibiotics in early life alter the murine colonic microbiome and adiposity

TL;DR: A model of adiposity is generated by giving subtherapeutic antibiotic therapy to young mice and changes in the composition and capabilities of the gut microbiome are evaluated, demonstrating the alteration of early-life murine metabolic homeostasis through antibiotic manipulation.
Journal ArticleDOI

Helminth Colonization Is Associated with Increased Diversity of the Gut Microbiota

TL;DR: It is suggested that helminth-colonized individuals had greater species richness and number of observed OTUs with enrichment of Paraprevotellaceae, especially with Trichuris infection.
Journal ArticleDOI

IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue.

TL;DR: It is suggested that increased TGF-β during active inflammation in UC may lead to the loss of Th22 cells in the human intestinal mucosa.